Pharma Mar | PHM - 流动负债

金融业

EUR

EUR 395.08M

现金及等价物

EUR 17.82M

EUR 3.77M

EUR 283.42M

EUR 93.88M

EUR 49.42M

股息收益率

0.88

EUR 43.61M

EUR 44.96M

EPS每股收益

EUR 3.34

股本和储备

EUR 251.83M

EUR 86.7M

债务利息支出

EUR 117K

EUR 1.63M

EUR 36.68M

EUR 1.67B

EUR 59.67M

EUR 46.87M

EUR 43.61M

普通股股本

EUR 17.36M

17.41

EUR 40.2M

EUR 90.2M

销售和管理费用

EUR 17.31M

EUR 50.64M

贸易债权人

EUR 54.34M

应收帐款人

EUR 60.6M

	流动负债	更改		日
Akebia Therapeutics	USD 162.94M		29.56M	2025-12
Alaunos Therapeutics	USD 921K		153K	2025-09
Almirall	EUR 350.64M		52.12M	2025-12
Avita Medical	AUD 62.68M		77K	2025-12
Dianthus Therapeutics	USD 30.73M		6.88M	2025-12
Ionis Pharmaceuticals	USD 783M		120.46M	2025-12
IQVIA Holdings	USD 8.34B		170M	2025-12
Laboratorios Farma	EUR 199.84M		121.75M	2023-12
Moderna	USD 1.99B		306M	2025-12
Organon & Co	USD 2.68B		117M	2025-09
Pharma Mar	EUR 93.88M		4.94M	2025-12
Revvity	USD 1.33B		108.5M	2025-12
Tectonic Therapeutic	USD 9.67M		293K	2025-12
Viatris	USD 7.09B		269.8M	2025-12
Xeris Pharmaceuticals	USD 109.57M		6.63M	2025-12